Latest Insider Transactions at Repligen Corp (RGEN)
This section provides a real-time view of insider transactions for Repligen Corp (RGEN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of REPLIGEN CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of REPLIGEN CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 26
2022
|
Rohin Mhatre |
BUY
Grant, award, or other acquisition
|
Direct |
1,202
+42.01%
|
-
|
|
May 25
2022
|
Karen A Dawes |
SELL
Open market or private sale
|
Direct |
14,715
-3.42%
|
$2,221,965
$151.1 P/Share
|
|
May 13
2022
|
Jon Snodgres Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
712
-1.78%
|
$106,800
$150.4 P/Share
|
|
May 13
2022
|
Christine Gebski |
SELL
Payment of exercise price or tax liability
|
Direct |
335
-0.97%
|
$50,250
$150.4 P/Share
|
|
May 13
2022
|
Ralf Kuriyel Senior VP, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
712
-3.42%
|
$106,800
$150.4 P/Share
|
|
Apr 01
2022
|
James Bylund Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
335
-3.33%
|
$62,980
$188.02 P/Share
|
|
Mar 16
2022
|
Manner Carrie Eglinton |
BUY
Open market or private purchase
|
Direct |
625
+22.89%
|
$109,375
$175.02 P/Share
|
|
Mar 08
2022
|
Jon Snodgres Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,166
+5.02%
|
$191,636
$46.7 P/Share
|
|
Mar 01
2022
|
Anthony Hunt |
SELL
Payment of exercise price or tax liability
|
Direct |
7,292
-3.53%
|
$1,414,648
$194.06 P/Share
|
|
Mar 01
2022
|
Thomas F Ryan Jr Director |
SELL
Open market or private sale
|
Direct |
2,000
-34.81%
|
$396,000
$198.03 P/Share
|
|
Mar 01
2022
|
Thomas F Ryan Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+22.44%
|
$38,000
$38.76 P/Share
|
|
Feb 28
2022
|
Christine Gebski |
SELL
Payment of exercise price or tax liability
|
Direct |
598
-1.71%
|
$117,208
$196.7 P/Share
|
|
Feb 28
2022
|
Anthony Hunt |
SELL
Payment of exercise price or tax liability
|
Direct |
16,538
-3.86%
|
$3,241,448
$196.7 P/Share
|
|
Feb 28
2022
|
Anthony Hunt |
BUY
Grant, award, or other acquisition
|
Direct |
30,074
+12.03%
|
-
|
|
Feb 28
2022
|
Jon Snodgres Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,129
-4.23%
|
$613,284
$196.7 P/Share
|
|
Feb 28
2022
|
Jon Snodgres Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,922
+13.42%
|
-
|
|
Feb 28
2022
|
Ralf Kuriyel Senior VP, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
2,057
-4.8%
|
$403,172
$196.7 P/Share
|
|
Feb 28
2022
|
Ralf Kuriyel Senior VP, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
4,234
+15.89%
|
-
|
|
Feb 27
2022
|
Christine Gebski |
SELL
Payment of exercise price or tax liability
|
Direct |
462
-1.3%
|
$90,552
$196.7 P/Share
|
|
Feb 27
2022
|
Anthony Hunt |
SELL
Payment of exercise price or tax liability
|
Direct |
2,754
-1.41%
|
$539,784
$196.7 P/Share
|
|
Feb 27
2022
|
Jon Snodgres Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
695
-2.07%
|
$136,220
$196.7 P/Share
|
|
Feb 27
2022
|
Ralf Kuriyel Senior VP, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
477
-2.49%
|
$93,492
$196.7 P/Share
|
|
Feb 24
2022
|
James Bylund Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
188
-1.83%
|
$35,532
$189.21 P/Share
|
|
Feb 24
2022
|
James Bylund Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,366
+24.71%
|
-
|
|
Feb 24
2022
|
Christine Gebski |
SELL
Payment of exercise price or tax liability
|
Direct |
181
-0.51%
|
$34,209
$189.21 P/Share
|
|
Feb 24
2022
|
Christine Gebski |
BUY
Grant, award, or other acquisition
|
Direct |
2,124
+5.62%
|
-
|
|
Feb 24
2022
|
Ralf Kuriyel Senior VP, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
188
-0.97%
|
$35,532
$189.21 P/Share
|
|
Feb 24
2022
|
Ralf Kuriyel Senior VP, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
2,126
+9.92%
|
-
|
|
Feb 24
2022
|
Jon Snodgres Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
269
-0.79%
|
$50,841
$189.21 P/Share
|
|
Feb 24
2022
|
Jon Snodgres Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,443
+9.22%
|
-
|
|
Feb 24
2022
|
Anthony Hunt |
SELL
Payment of exercise price or tax liability
|
Direct |
1,170
-0.59%
|
$221,130
$189.21 P/Share
|
|
Feb 24
2022
|
Anthony Hunt |
BUY
Grant, award, or other acquisition
|
Direct |
15,855
+7.45%
|
-
|
|
Feb 17
2022
|
Jon Snodgres Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
332
-1.08%
|
$60,424
$182.42 P/Share
|
|
Feb 17
2022
|
Jon Snodgres Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
900
+2.84%
|
-
|
|
Feb 17
2022
|
Christine Gebski |
SELL
Payment of exercise price or tax liability
|
Direct |
224
-0.66%
|
$40,768
$182.42 P/Share
|
|
Feb 17
2022
|
Christine Gebski |
BUY
Grant, award, or other acquisition
|
Direct |
450
+1.32%
|
-
|
|
Feb 17
2022
|
Ralf Kuriyel Senior VP, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
175
-1.01%
|
$31,850
$182.42 P/Share
|
|
Feb 17
2022
|
Ralf Kuriyel Senior VP, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
450
+2.53%
|
-
|
|
Feb 17
2022
|
James Bylund Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
334
-4.62%
|
$60,788
$182.42 P/Share
|
|
Feb 17
2022
|
James Bylund Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
900
+11.08%
|
-
|
|
Dec 14
2021
|
Ralf Kuriyel Senior VP, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
445
-2.56%
|
$112,140
$252.53 P/Share
|
|
Nov 18
2021
|
Anthony Hunt |
SELL
Open market or private sale
|
Direct |
17,355
-1.29%
|
$4,807,335
$277.22 P/Share
|
|
Nov 18
2021
|
Anthony Hunt |
SELL
Exercise of conversion of derivative security
|
Direct |
10,000
-4.77%
|
$320,000
$32.4 P/Share
|
|
Nov 10
2021
|
Karen A Dawes |
SELL
Open market or private sale
|
Direct |
4,783
-0.51%
|
$1,267,495
$265.15 P/Share
|
|
Nov 10
2021
|
Karen A Dawes |
SELL
Exercise of conversion of derivative security
|
Direct |
4,783
-4.74%
|
$124,358
$26.12 P/Share
|
|
Nov 04
2021
|
Thomas F Ryan Jr Director |
SELL
Open market or private sale
|
Direct |
1,000
-7.5%
|
$288,000
$288.0 P/Share
|
|
Nov 02
2021
|
Karen A Dawes |
SELL
Open market or private sale
|
Direct |
2,400
-0.37%
|
$727,200
$303.19 P/Share
|
|
Nov 02
2021
|
Thomas F Ryan Jr Director |
BUY
Open market or private sale
|
Direct |
1,285
+8.79%
|
$388,070
$302.0 P/Share
|
|
Nov 02
2021
|
Thomas F Ryan Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,285
+8.08%
|
$164,480
$128.18 P/Share
|
|
Oct 29
2021
|
Nicolas Barthelemy |
SELL
Open market or private sale
|
Direct |
1,645
-29.57%
|
$473,760
$288.2 P/Share
|